EdgarLookup

Envoy Medical, Inc. — Insider Transactions

Form 4 filings by directors, officers, and 10%+ shareholders

SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.

Overview All Filings Annual Quarterly Insiders
Insider Title Type Shares Price Value Owns After Date
Lucas Brent T. Chief Executive Officer Award / Grant 18,105 $0.71 $12,855 234,590 Nov 28, 2025
Patel Mona Chetan Purchase 2,500 $1.47 $3,675 20,000 Jun 11, 2025
Patel Mona Chetan Purchase 10,000 $1.46 $14,600 17,500 Jun 6, 2025
BRYNELSEN CHARLES Purchase 35,000 $1.65 $57,750 50,000 May 22, 2025
Kantor Susan Other 34,705 77,887 Dec 23, 2024
Anzu SPAC GP I LLC C 1,028,986 2,028,986 Dec 23, 2024
Lucas Brent T. Chief Executive Officer Award / Grant 7,742 $1.29 $9,987 216,485 Nov 30, 2024
Patel Mona Chetan Purchase 2,500 $2.28 $5,700 7,500 Nov 20, 2024
Kantor Susan Other 18,182 43,182 Nov 19, 2024
Haring-Smith Whitney Other 1,000,000 1,000,000 Nov 19, 2024
Patel Mona Chetan Purchase 4,000 $3.33 $13,320 5,000 Sep 9, 2024
Lucas Brent T. Chief Executive Officer Other 10,176 12,720 Jun 24, 2024
Lucas Brent T. Chief Executive Officer Purchase 2,380 $0.92 $2,190 120,831 Nov 21, 2023
DEWBREY DIANE L C 25,000 25,000 Sep 29, 2023
Hirsch Daniel J. CFO and Corporate Secretary C 25,000 25,000 Sep 29, 2023
Kantor Susan C 25,000 25,000 Sep 29, 2023
Huskins Priya Cherian C 25,000 25,000 Sep 29, 2023
Anzu SPAC GP I LLC C 2,490,000 2,490,000 Sep 29, 2023